Insurers will take drug costs, frequency of use, and other factors into account as they set premium amounts for the 2026 plan ...

Medicare enrollees who buy the optional Part D drug benefit may see price hikes of up to $50 a month when they shop for next year’s coverage.

To help Medicare plans better manage members with high drug expenses, Prime Therapeutics has launched an AI-driven tool to ...

The drug industry’s top lobbying group is appealing its latest loss in its challenge to Medicare’s Drug Price Negotiation ...

A federal appeals panel voted 2-to-1 against a group of international aid groups, ruling they did not have the legal standing to bring a lawsuit. Meanwhile, the Trump administration has ordered a ...

Drug companies have formed a new group to present lawmakers with research on what the industry sees as the negative impacts ...

Millions of Americans aged 65 and older rely on Medicare Part D to manage the cost of their prescription medications. As the healthcare landscape shifts, this crucial benefit faces financial and ...

Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, ...

The Inflation Reduction Act (IRA) authorized the federal government to force prescription drug manufacturers to "negotiate" drug prices for ...